News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Katsuaki Maehara: EGFRm Unresectable Stage III lung cancer in LAURA and POLESTAR trials
Katsuaki Maehara/X
Oct 29, 2024, 17:46

Katsuaki Maehara: EGFRm Unresectable Stage III lung cancer in LAURA and POLESTAR trials

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

“EGFRm Unresectable Stage III lung cancer.

LAURA and POLESTAR.

INDIRECT

  • Tend to ‘high’ disease progression or death. (IMO)
  • Are EGFRm positive lung cancers still highly malignant ? (IMO)
  • It seems as if it is a systemic disease. (IMO).”

Katsuaki Maehara

cancer Katsuaki Maehara LAURA Lung cancer OncoDaily Oncology Polestar systemic disease
Special Coverage
Drugs
Jun 30, 2025, 01:40
Vorasidenib (Voranigo): What patients need to know?
Blog
Jun 29, 2025, 18:36
Tingting Zhang: The Group Shot of Presenters and Panelists in MASCC 2025
Blog
Jun 29, 2025, 18:28
Cathy Eng: Vanderbilt University Medical Center Young Adult Cancer June Newsletter
Blog
Jun 29, 2025, 18:19
Applications are Open for the ASH Global Research Award
Blog
Jun 29, 2025, 18:10
Fumiko Ladd Chino: CMS Announces New Prior Authorization Barriers to Traditional Medicare
Blog
Jun 29, 2025, 17:49
Michael Lemma: Proud to Be a Presenter and a Panelist at the Best of ASCO Africa on Head and Neck Cancer
Career
Jun 29, 2025, 17:43
Benjamin Besse: Honoured to Have Been Appointed President-Elect of the EORTC
Science
Jun 29, 2025, 17:30
George Vlachogiannis: Salivary Biomarkers May Aid Early Detection of Periodontitis During Radiotherapy
Blog
Jun 29, 2025, 17:22
Nikolina Dodlek: It Was Great Honour to Present my PhD Work at MASCC2025
Blog
Jun 29, 2025, 17:17
EORTC Announces Benjamin Besse as President-Elect and New Co-Chairs of Scientific Chairs Council
Blog
Jun 29, 2025, 17:11
Herbert Loong Celebrates ESMO’s 50th Anniversary Reflecting on Progress and Future in Oncology
Blog
Jun 29, 2025, 17:04
Sami Mansfield: Two of the Toughest Challenges after Cancer-Related Menopause